We are live on
!
Find out more
NM
Newtyn Management Portfolio holdings
AUM
$936M
1-Year Est. Return
27.23%
This Fund
S&P 500
This Quarter
Est. Return
-7.05%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$533M
AUM Growth
+$30.6M
(+6.1%)
Cap. Flow
+$69.5M
Cap. Flow
% of AUM
13.05%
Top 10 Holdings %
Top 10 Hldgs %
65.84%
Holding
49
New
9
Increased
10
Reduced
14
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QuidelOrtho
QDEL
|
+$45.6M |
| 2 |
Solventum
SOLV
|
+$42.5M |
| 3 |
BrightView Holdings
BV
|
+$22.3M |
| 4 |
FSP
Franklin Street Properties
FSP
|
+$13.5M |
| 5 |
TSVT
2seventy bio
TSVT
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$27.7M |
| 2 |
Cannae Holdings
CNNE
|
+$25.9M |
| 3 |
Mitek Systems
MITK
|
+$12.3M |
| 4 |
PAR Technology
PAR
|
+$12M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.47% |
| 2 | Communication Services | 18.1% |
| 3 | Real Estate | 13.17% |
| 4 | Technology | 12.06% |
| 5 | Energy | 6.84% |
Similar funds
APM
PWAM
LJAC
NI
MCM
TS
TW
PGA
Newtyn Management's Q2 2024 Portfolio in Review
As of Q2 2024, Newtyn Management held 49 positions worth $533M, up 6.1% from $502M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Newtyn Management deployed $69.5M of net new capital in Q2 2024, opening 9 new positions and adding to 10 existing holdings. Its largest new stake was QuidelOrtho: 1,115,000 shares worth $37M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 22% a quarter earlier, followed by Communication Services and Real Estate.
On the sell side, the largest reduction was Cannae Holdings, an estimated $25.9M trimmed.
- Newtyn Management's largest Q2 2024 buy was QuidelOrtho: 1,115,000 shares worth $37M.
- Newtyn Management added most to Cogent Communications in Q2 2024, an estimated $8.95M increase.
- Newtyn Management's biggest Q2 2024 reduction was Cannae Holdings, cutting an estimated $25.9M.
- Newtyn Management fully exited Merrimack Pharmaceuticals, Inc. in Q2 2024, selling an estimated $27.7M.
- Newtyn Management's ten largest holdings make up 66% of its $533M portfolio in Q2 2024.
- Newtyn Management opened 9 new positions and closed 9 in Q2 2024.
- Newtyn Management's portfolio value rose 6.1% quarter-over-quarter to $533M.
Based on Newtyn Management's 13F filing for Q2 2024, filed 14 Aug 2024.